• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIZU OLYMPUS CO., LTD. EVIS LUCERA DUODENOVIDEOSCOPE Back to Search Results
Model Number TJF-260V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Pancreatitis (4481)
Event Date 01/18/2024
Event Type  Injury  
Event Description
Olympus reviewed the following literature titled "a comparison of diagnostic utility of new endoscopic scraper combined cell block method and conventional brush catheter for biliary tract cancer".Literature summary background/aims: the sensitivities of endoscopic trans-papillary pathologic diagnosis of biliary tract cancer (btc) are unsatisfactory.Recently, the diagnostic utility of the endoscopic scraper device, trefle for biliary stricture has been reported.The trefle can be guided to the target biliary stricture over the guidewire and is as easy to use as the conventional brush catheter (cbc).This study evaluated the efficacy and safety of trefle-assisted tissue acquisition combined cell block method and cbc cytology for biliary strictures due to btcs.Methods: we retrospectively reviewed consecutive patients with biliary strictures in whom cbc cytology or trefle-assisted tissue acquisition under endoscopic retrograde cholangiopancreatography was performed for suspected btcs from january 2015 to june 2022 at our institution.Results: 173 patients (cbc group; n = 55, trefle group; n = 118) were enrolled in this study.The sensitivity, specificity, and accuracy of cbc cytology for btc were 68.3%/100%/76.4%.On the other hand, the sensitivity, specificity, and accuracy of trefle-assisted tissue acquisition for btc were 93.7%/95.7%/94.1%, showing superior sensitivity (p < 0.001) and accuracy (p = 0.002) compared to that of cbc.Post-ercp pancreatitis (pep) occurred in 11 (20.0%) in the cbc group and 13 (11%) in the trefle group.The incidence of pep tended to be higher in both groups, but the difference between the two groups was not significant.The pep was considered severe in three (5.5%) patients in the cbc group and five (4.2%) in the trefle group.One case of post-est bleeding was observed in the cbc group but improved with endoscopic therapy.Conclusions: compared to cbc cytology, trefle-assisted tissue acquisition has superior diagnostic performance while maintaining procedural simplicity and is considered useful for diagnosing malignant biliary stricture.Type of adverse events/number of patients pancreatitis (32) bleeding (1).
 
Manufacturer Narrative
This report is related to the following linked patient identifiers: ¿ (b)(6).Should additional relevant information become available, a supplemental report will be submitted¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA DUODENOVIDEOSCOPE
Type of Device
DUODENOVIDEOSCOPE
Manufacturer (Section D)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA  965-8520
Manufacturer (Section G)
AIZU OLYMPUS CO., LTD.
3-1-1 niiderakita
aizuwakamatsu-shi, fukushima 965-8 520
JA   965-8520
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18855703
MDR Text Key337099698
Report Number9610595-2024-04874
Device Sequence Number1
Product Code FDT
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/07/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTJF-260V
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received02/14/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-